ITMCTR1900002523RecruitingPhase 1
Effects of edaravone on early postoperative cognitive function in elderly patients undergoing hip joint replacement surgery
Shanghai Pudong Hospital0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Patients aged 60 years and over; received hip joint replacement surgery; informed consent; ASA I or II.
Exclusion Criteria
- •History of psychiatric disorders, cerebrovascular diseases and diabetes; long term use of nervous and mental system drugs (such as sedative hypnotics and antidepressants); history of alcohol abuse; severe impairment on speaking, hearing and vision that difficult to communicate; MMSE score < 23 one day before surgery.
Investigators
Similar Trials
Not yet recruiting
Phase 3
Effectivnes of edaravone on ischemic strokeIschemic stroke.Cerebral infarctionIRCT20240224061102N1Yasouj University of Medical Sciences60
Completed
Phase 3
Edaravone in COVID-19IRCT20200317046797N6Tabriz University of Medical Sciences30
Completed
Phase 2
Effect of edaravone against consciousness impairment after encephalitisJPRN-UMIN000010052niversity of Tsukuba10
Recruiting
Phase 3
Efficacy of Edaravone with Thrombolysis in Acute Ischemic StrokeIRCT20210530051440N1Zanjan University of Medical Sciences244
Completed
Not Applicable
Clinical study of the effectiveness of edaravone for the oxidative stress in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis (ALS)JPRN-UMIN000024854Okayama university20
